⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29363423 | 1.00 | — | — | |
| SCHEMBL5700591 | 0.77 | — | — | |
| SCHEMBL6385216 | 0.77 | — | — | |
| SCHEMBL31133396 | 0.76 | MYC (0.62) | — | |
| SCHEMBL9792895 | 0.76 | MYC (0.62) | — | |
| SCHEMBL1145922 | 0.74 | — | — | |
| SCHEMBL995799 | 0.74 | CLK4 (0.44) | — | |
| SCHEMBL131627 | 0.74 | — | — | |
| SCHEMBL29598148 | 0.74 | CLK4 (0.44) | — | |
| SCHEMBL1094766 | 0.74 | MYC (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 806 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116375636-A | Novel method for synthesizing 4-fluoropyridine-2-carbonitrile | 浙江工业大学 | 2023-07-04 | — | — | CN | claimed |
| CN-112250622-B | Preparation method of 4-fluoropyridine-2-amine | 山东省海洋化工科学研究院 | 2022-05-27 | — | — | CN | claimed |
| CN-112279809-A | Preparation method of 2-cyano-4-fluoropyridine | 山东省海洋化工科学研究院 | 2021-01-29 | — | — | CN | claimed |
| CN-112250622-A | Preparation method of 4-fluoropyridine-2-amine | 山东省海洋化工科学研究院 | 2021-01-22 | — | — | CN | claimed |
| CN-103664768-A | Compound 2-(cyclopropylamino)-3-carboxylic acid-4-chloropyridine and application thereof | QINGDAO WENCHUANG TECH CO LTD | 2014-03-26 | — | — | CN | claimed |
| WO-2026101698-A1 | HEPCIDIN MIMETIC COMPOUNDS AND USES THEREOF | PROTAGONIST THERAPEUTICS, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| US-12624051-B2 | Macrocyclic compounds, compositions, and methods of using thereof | GENZYME CORPORATION (US) | 2026-05-12 | — | — | US | disclosed |
| US-12617774-B2 | Substituted indole compounds and methods of use thereof | NOVARTIS AG (CH) | 2026-05-05 | — | — | US | disclosed |
| EP-4142732-B1 | METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS | GLOBAL BLOOD THERAPEUTICS INC (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-3565808-B1 | COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS | ARDELYX INC (US) | 2026-03-04 | — | — | EP | disclosed |
| US-12559502-B2 | Thieno pyrimidines as ferroportin inhibitors | Global Blood Therapeutics, Inc (US) | 2026-02-24 | — | — | US | disclosed |
| US-20260008786-A1 | MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF | SCHRODINGER, LLC | 2026-01-08 | — | — | US | disclosed |
| US-4170654-A | Antihypertensive compositions containing N-heterocyclicalanines and α- | MERCK & CO., INC. (US) | 1979-10-09 | — | — | US | disclosed |
| US-4160835-A | Antihypertensive compositions containing an arylsubstituted alanine and a phenyl hydrazinopropionic acid | MERCK & CO., INC. (US) | 1979-07-10 | — | — | US | disclosed |
| US-4112100-A | INCREASING THE ENDOGENOUS PRODUCTION OF PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1978-09-05 | — | — | US | disclosed |
| US-4088766-A | PRODUCTION OF PROSTAGLANDINS IN MAMMALS | THE UPJOHN COMPANY (US) | 1978-05-09 | — | — | US | disclosed |
| US-4008326-A | INCREASING PRODUCTION OF PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1977-02-15 | — | — | US | disclosed |
| US-4001256-A | PROSTAGLANDIN PRODUCTION IN MAMMALS | THE UPJOHN COMPANY (US) | 1977-01-04 | — | — | US | disclosed |
| US-3932641-A | THIOACETAMIDES | SMITHKLINE CORPORATION (US) | 1976-01-13 | — | — | US | disclosed |
| US-3931162-A | N-Aminomethyl heterocyclic thioacetamides | SMITHKLINE CORPORATION (US) | 1976-01-06 | — | — | US | disclosed |